Its early uptake curve ran about 4.4 times steeper than Zepbound's, and injectable Wegovy scripts held steady after the pill arrived, per Annals of Internal Medicine.
Recap by typeshit. Full story at Medical Professionals Reference.
PHL17 shares findings that people on Ozempic and similar drugs are cutting alcohol spending at bars, restaurants and home.
Gaetano Santulli's team surveys approved oral options and late-stage pill candidates, arguing they could reach patients who avoid injections.
After 12 months, GLP-1 users shed 14.8% of the weight they had regained versus 8.1% for nonusers. Researchers stress the study was observational and small.
Omer Raheem says he presented his team's work on GLP-1 therapies past weight loss at the ISSM Journals Webinar 2026.
Johns Hopkins researchers found its early uptake curve was 4.4 times steeper than Zepbound's, and injectable Wegovy prescriptions didn't fall after the pill arrived.
EMY says the FDA has added a new warning covering weight loss drugs such as Wegovy. The listing gives no detail on what the warning says, so tap through.
Loading…